Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta‐analysis.
K Sakuma, T Kishi, S Sanji, I Nomura… - Psychiatry & …, 2023 - search.ebscohost.com
Both pooled PDE5-Is and individual PDE5-Is (sildenafil and vardenafil) outperformed the
placebo in the improvement of all IIEF domain scores. A recent meta-analysis recommended …
placebo in the improvement of all IIEF domain scores. A recent meta-analysis recommended …
Phosphodiesterase type 5 (PDE5) inhibitors in erectile dysfunction: the proper drug for the proper patient
Introduction Erectile dysfunction (ED) is a very common multidimensional disorder affecting
men worldwide. Physical illness, reaction to life stresses, or an unhappy couple relationship …
men worldwide. Physical illness, reaction to life stresses, or an unhappy couple relationship …
Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature
G Lombardi, F Nelli, M Celso… - The Journal of …, 2012 - academic.oup.com
Introduction Erectile dysfunction (ED) is reported in a high percentage of patients with
central neurological disorders (CND). Aim An up-to-date review on oral phosphodiesterase …
central neurological disorders (CND). Aim An up-to-date review on oral phosphodiesterase …
Sexual Psychopharmacology: Important Symptomatic Treatment in Depression and Anxiety?
RH Belmaker, P Lichtenberg - … : A Concise Guide Exploring the Limits of …, 2023 - Springer
Sexual dysfunction is an important part of symptomatology in depression and anxiety and
can be a serious side effect of treatment of depression or psychosis. PDE-5 inhibitor …
can be a serious side effect of treatment of depression or psychosis. PDE-5 inhibitor …
PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes
RC Rosen, KE McKenna - Annual review of sex research, 2002 - Taylor & Francis
Abstract Phosphodiesterase type-5 (PDE-5) inhibitors are a new class of vasoactive drugs
that have been developed for treatment of erectile dysfunction (ED). The mechanism of …
that have been developed for treatment of erectile dysfunction (ED). The mechanism of …
Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis
A Tsertsvadze, HA Fink, F Yazdi… - Annals of internal …, 2009 - acpjournals.org
Background: Erectile dysfunction (ED) is a common male sexual disorder. The relative
benefits and harms of pharmacologic therapies for ED, as well as the value of hormonal …
benefits and harms of pharmacologic therapies for ED, as well as the value of hormonal …
Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction
AC Axilrod - Current medical research and opinion, 2007 - Taylor & Francis
Background: Erectile dysfunction (ED) is increasingly being recognized as a sentinel marker
of future subsequent cardiovascular disease (CVD). Predicted increases in the prevalence …
of future subsequent cardiovascular disease (CVD). Predicted increases in the prevalence …
Which is first? The controversial issue of precedence in the treatment of male sexual dysfunctions
Introduction In male sexual dysfunction (MSD), the presence of sexual comorbidities is
relatively frequent. However, what is still a matter of controversy is what the first‐line therapy …
relatively frequent. However, what is still a matter of controversy is what the first‐line therapy …
Prescribing PDE5 Inhibitors: Best Practices, Common Practices, and Controversies
MR Klein, AW Shindel - Current Sexual Health Reports, 2023 - Springer
Abstract Purpose of Review Erectile dysfunction (ED) is an increasingly common concern
that has been a topic of interest to men (and their partners) since time immemorial. In the …
that has been a topic of interest to men (and their partners) since time immemorial. In the …
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitors
EA Jannini, LR DeRogatis, E Chung… - The Journal of Sexual …, 2012 - academic.oup.com
Introduction Several methods have been so far proposed to compare the effectiveness of the
three available phosphodiesterase type 5 inhibitors (PDE5Is). Methods Two urologists (EC …
three available phosphodiesterase type 5 inhibitors (PDE5Is). Methods Two urologists (EC …
相关搜索
- phosphodiesterase type erectile dysfunction
- phosphodiesterase type inhibitors for the treatment
- meta analysis inhibitors for the treatment
- phosphodiesterase type meta analysis
- pde5 inhibitors erectile dysfunction
- hormonal treatments erectile dysfunction
- phosphodiesterase type patients in the management
- phosphodiesterase type pde5 inhibitors
- meta analysis erectile dysfunction
- meta analysis hormonal treatments
- phosphodiesterase type clinicians and patients